Evaluation of vitamin D3 Supplementation on Serum Level of P-selectin and hs-CRP
Early Phase 1
- Conditions
- Thrombosis.Other venous embolism and thrombosis
- Registration Number
- IRCT201112068307N1
- Lead Sponsor
- Vice chancelor of reseasrch, TUMS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Inclusin criteria : patients with confirmed thrombosis up to 1 months; patients with 18 years old and over and consented patients.
Exclusion criteria: hypercalcemia, nephrolithiasis,Sarcoidosis, vitamin D supplementation,malabsorbtion syndrome, Severe infection, uncontrolled autoimmune and inflammatory diseases and pregnancy and any drugs, conditions and diseases that affect the P-selectin levels.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method P-selectin. Timepoint: before and 1 month after intervention. Method of measurement: ELAISA, lab.;Hs-CRP. Timepoint: before and 1 month after intervention. Method of measurement: ELAISA, lab.
- Secondary Outcome Measures
Name Time Method 25-hydroxy vitamin D3. Timepoint: before and 1 month after intervention. Method of measurement: Radioimmunoassay.